Skip to main content

Life Sciences

By Emily Olsen | 02:14 pm | April 26, 2022
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
By Emily Olsen | 11:15 am | April 26, 2022
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
By Emily Olsen | 12:39 pm | April 25, 2022
The collection by Getlabs will cost users a convenience fee starting at $25.
By Emily Olsen | 03:20 pm | April 21, 2022
The company, which uses artificial intelligence to make sense of unstructured clinical information like EHR data, raised $18 million in June 2021.
By Emily Olsen | 01:19 pm | April 21, 2022
Reify said it will use the investment to focus its tools on increased diversity in clinical trials.
By Emily Olsen | 02:52 pm | April 20, 2022
Also: Employer-focused mental health startup Spring Health makes two new hires, and Carrot Fertility adds to its medical team.
By Emily Olsen | 03:22 pm | April 19, 2022
Also: RPM company Blue Spark Technologies brought in $40 million in IP-backed debt financing, and Click Therapeutics secured a $15 million loan.
By Emily Olsen | 12:45 pm | April 19, 2022
This marks THREAD's third recent acquisition, including the inVibe deal announced early this year and the Modus Outcomes purchase from November.
By Laura Lovett | 12:43 pm | April 18, 2022
A new study in The Lancet found that a deep-learning algorithm was able to detect vision-threatening retinopathy with 94.7% accuracy. 
By Laura Lovett | 04:21 pm | April 12, 2022
The study did not find find a significant difference in depression symptoms between the intervention and control group.